PCI Pharma Services

PCI Pharma Services Contract Manufacturing & Development (CDMO) Profile

PCI is your world leading CDMO, providing integrated end-to-end drug development, manufacturing, and packaging solutions to increase product speed to market and opportunities for commercial success. PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades in the delivery of CDMO services. With 30 sites across Australia, Canada, North America, the UK and Europe and over 7,000+ dedicated employees, together, delivering life changing therapies to patients. Leading technology and continued investment enable us to deliver development to commercialization solutions throughout the product lifecycle, collaborating with our clients to improve the lives of patients globally.

CDMO Services:
Small Molecule; Biologics Drug Product Formulation (FDF); Clinical Trials materials and logistics; Packaging; Regulatory Services; Analytical Development Cartridges; Liquids; Lyophilized amps/vials; Pre-Filled Syringes (PFS); Semi-solids; Solids; Sterile Ampoules; Sterile Vials

Year Founded: 2012

Head Office: Philadelphia, United States

Number of Facilities: More than 10

Facility locations: Europe; North America

Website: Visit the PCI Pharma Services website

Linkedin: Connect on Linkedin

Current Capacity: Capacity across all drug product manufacturing and packaging sites